本页面由Tiger Trade Technology Pte. Ltd.提供服务

Virpax Pharmaceuticals, Inc.

0.0107
0.0000
成交量:- -
成交额:- -
市值:1.33万
市盈率:0.00
高:0.0107
开:0.0107
低:0.0107
收:0.0107
52周最高:11.75
52周最低:0.0000
股本:124.25万
流通股本:123.16万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-70.9103
每股收益(LYR):-70.9103
净资产收益率:-2364.82%
总资产收益率:-135.01%
市净率:-0.01
市盈率(LYR):0.00

数据加载中...

2025/07/21

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/04/03

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/04/03

重要事件披露

Form 8-K - Current report
2025/03/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/21

重要事件披露

Form 8-K - Current report
2025/03/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/06

重要事件披露

Form 8-K - Current report
2025/02/04

重要事件披露

Form 8-K - Current report
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/23

SEC问询函

Form CORRESP - Correspondence
2025/01/23

SEC问询函

Form CORRESP - Correspondence
2025/01/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/12/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/18

重要事件披露

Form 8-K - Current report
2024/12/13

重要事件披露

Form 8-K - Current report